Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
EMD Serono to Invest $12 Million to Expand Biopharmaceutical R&D Facility in Billerica, Massachusetts
Introduction EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12 million investment for the expansion of its RD facility in Billerica, Massachusetts Features The new building will span more than 30,000 squar
Allergan to invest $200 Million for Facility Expansion in Waco, Texas
Introduction Allergan plc, a leading global pharmaceutical company broke ground on a $200 million expansion of its Waco, Texas facility Features The expansion will add 322,000 square feet of manufacturing space to the current facility, nearly doubling its current footprint Add
Pfizer to invest $200 Million for New Biologics Clinical Manufacturing Facility in Andover, Massachusetts
Introduction Pfizer Inc broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts with an investment of $200 Million Features The New 175,000 sq ft stateoftheart facility that will enable the production of highquality, complex biologics
Pfizer to invest USD$350 Million for New World-Class Global Biotechnology Center in China
Introduction Pfizer Inc announced that it will invest approximately USD$350 million in the development of a stateoftheart Global Biotechnology Center in China Features This innovative facility will be Pfizers third biotechnology center globally and the first in Asia
Allergan to invest $200 Million for Facility Expansion in Waco, Texas
Introduction Allergan plc, a leading global pharmaceutical company broke ground on a $200 million expansion of its Waco, Texas facility Features The expansion will add 322,000 square feet of manufacturing space to the current facility, nearly doubling its current footprint Add
EMD Serono to Invest $12 Million to Expand Biopharmaceutical R&D Facility in Billerica, Massachusetts
Introduction EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12 million investment for the expansion of its RD facility in Billerica, Massachusetts Features The new building will span more than 30,000 squar
Aurobindo Pharma USA Invests $31.7 million to Establish National Headquarters in Durham, North Carolina
Introduction The New Jerseybased Aurobindo Pharma USA maker of generic pharmaceuticals plans to invest over $317 million in a new stateoftheart national headquarters for specialty pharmaceutical RD Features Aurobindo Pharma USA will establish a new RD and manufac
Novo Nordisk Breaks Ground on $2 billion Production Facility in Clayton, North Carolina
Introduction Novo Nordisk broke ground on its new 2 billion US dollar production facility in Clayton, North Carolina Features The facility will produce active pharmaceutical ingredients API for a range of Novo Nordisks current and future GLP1 and insulin product
Braeburn Pharmaceuticals Invests $19.9 Million to Establish Manufacturing-Research Center in Durham County, North Carolina
Introduction Braeburn Pharmaceuticals, Inc will invest $199 million to establish a manufacturing and research facility in Durham County, North Carolina Features The company will create 52 new jobs during the next five years We are excited to be building our sta
Athenex to invest $1.62 billion in drug discovery and advanced manufacturing partnership
Introduction Athenex formerly Kinex plans to invest $162 billion in drug discovery and advanced manufacturing partnership, creating 900 jobs in Dunkirk and 500 jobs in Buffalo over the next ten years Features This announcement, made possible by a partnership with the SUNY Po
